newsfilter
← Latest News
PR Newswire·

Compugen to Release Third Quarter 2026 Results on Monday, November 9, 2026

HOLON, Israel, Oct. 26, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered by AI, today announced